Copyright
©The Author(s) 2023.
World J Clin Cases. Oct 16, 2023; 11(29): 7017-7025
Published online Oct 16, 2023. doi: 10.12998/wjcc.v11.i29.7017
Published online Oct 16, 2023. doi: 10.12998/wjcc.v11.i29.7017
Group | Time | SDS scale score | HAMD-24 scale score |
Control group (n = 45) | Before treatment | 59.22 ± 5.23 | 20.22 ± 3.22 |
After 4 wk of treatment | 50.19 ± 5.16 | 10.88 ± 1.22 | |
t value | 8.245 | 18.196 | |
P value | < 0.001 | < 0.001 | |
Experimental group (n = 35) | Before treatment | 60.19 ± 5.16 | 20.26 ± 3.17 |
After 4 wk of treatment | 44.22 ± 5.03 | 6.95 ± 1.16 | |
t value | 13.111 | 23.327 | |
P value | < 0.001 | < 0.001 |
- Citation: Yu J, Xu FQ. Clinical efficacy and safety of Guipi decoction combined with escitalopram oxalate tablets in patients with depression. World J Clin Cases 2023; 11(29): 7017-7025
- URL: https://www.wjgnet.com/2307-8960/full/v11/i29/7017.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i29.7017